Applaud Medical Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 24

Employees
  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $5.71M

  • Investors
  • 13

Applaud Medical General Information

Description

Developer of a medical device designed to improve patient outcomes with new products and procedures. The company's device addresses the painful condition of kidney stones with an innovative, non-invasive treatment, enabling patients to effectively treat urinary stone disease with a simple outpatient procedure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Drug Discovery
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (415) 000-0000

Applaud Medical Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Applaud Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B1) 27-Jul-2022 $5.71M 000.00 0000 Completed Generating Revenue
7. Grant 15-May-2021 00000 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 11-Feb-2021 000.00 000.00 0000 Completed Generating Revenue
5. Debt - PPP 12-Apr-2020 00000 000.00 Completed Generating Revenue
4. Early Stage VC (Series A2) 23-May-2018 00.00 000.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 13-Apr-2016 00.00 00.00 0000 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Seed Round 01-May-2015 Completed Generating Revenue
To view Applaud Medical’s complete valuation and funding history, request access »

Applaud Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.00
Series A2 7,499,222 $0.000100 8% $0.97 $0.97 1x $0.97 11.42%
Series A1 6,527,765 $0.000100 8% $0.79 $0.79 1x $0.79 9.47%
To view Applaud Medical’s complete cap table history, request access »

Applaud Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed to improve patient outcomes with new products and procedures. The company's devic
Other Devices and Supplies
San Francisco, CA
24 As of 2023
000.00
000 0000-00-00
00000000000 000.00

000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
00000000000 0000000
San Mateo, CA
0 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

000000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
0000000000000
Stockholm, Sweden
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Applaud Medical Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sonomotion Venture Capital-Backed San Mateo, CA 0 000.00 00000000000 000.00
0000000 000000 Venture Capital-Backed Stockholm, Sweden 00 000.00 00000000000 000.00
00000 Formerly VC-backed Durham, NC 00 00000 000000000 00000
0000000 Venture Capital-Backed Zurich, Switzerland 0 00.00 0000000000 0 00.00
00000000 000000000 Venture Capital-Backed 00 00000 00000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Applaud Medical Patents

Applaud Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210236524-A1 Phospholipid compounds and formulations Active 28-Jan-2020 0000000000
US-11464792-B2 Phospholipid compounds and formulations Active 28-Jan-2020 0000000000 00
US-20220387458-A1 Methods of manufacturing microspheres Pending 28-Jan-2020 0000000000 0
US-20220395517-A1 Method of treating urolithiasis Pending 28-Jan-2020 0000000000 0
US-10953023-B1 Phospholipid compounds and formulations Active 28-Jan-2020 A61K31/685
To view Applaud Medical’s complete patent history, request access »

Applaud Medical Executive Team (8)

Name Title Board Seat Contact Info
Thomas Kenny Ph.D Co-Founder, Chairman, Chief Science & Technical Advisor
Paul Molloy Chief Executive Officer & Board Member
Claire Mills Co-Founder & Ultrasound Imaging and Clinical Affairs Specialist
Ben Zadik Chief Financial Officer
Daniel Laser Ph.D Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Applaud Medical Board Members (16)

Name Representing Role Since
Alex Andrianopoulos Self Board Member 000 0000
Barry Templin Self Board Member 000 0000
Biao He Applaud Medical Board Member 000 0000
Dongxue Wang Self Board Member 000 0000
Gordon Saul Applaud Medical Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Applaud Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Applaud Medical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Berkeley Catalyst Fund Venture Capital Minority 000 0000 000000 0
Constellar Ventures Venture Capital Minority 000 0000 000000 0
KCK MedTech Venture Capital Minority 000 0000 000000 0
Photon Fund Venture Capital Minority 000 0000 000000 0
SVE Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »